Download presentation
Presentation is loading. Please wait.
1
GEF Session 9A Introduction to the Economics of Pollution Control: Health Issues John A. Dixon johnkailua@aol.com Ashgabad, November, 2005 Adapted from materials prepared by Maureen Cropper The World Bank
2
GEF Caspian EVE 2005/UNDP and WBI John A. Dixon, Economics of Pollution Control What Questions Can Economic Valuation/BCA Help Answer? How stringent should environmental standards be for Air quality? Surface water quality? Drinking water quality? What about POPs? Any other pollutant?
3
GEF Caspian EVE 2005/UNDP and WBI John A. Dixon, Economics of Pollution Control Benefits and Costs of Pollution Control Four categories of benefits could be examined: Human health (the focus here) Visibility (amenity values) Ecological Effects (and ecosystem services) Agricultural Benefits (change in production)
4
GEF Caspian EVE 2005/UNDP and WBI John A. Dixon, Economics of Pollution Control Valuing Environmental Health Effects Damage Function Approach Value of number of cases of illness/death avoided = Number of Cases Avoided * Value per Case Value per Case Avoided should reflect individual’s willingness to pay (WTP) to avoid illness or risk of death Human Capital/Cost of Illness Approach, which focuses on lost productivity, medical costs, generally serves as a lower bound to WTP
5
GEF Caspian EVE 2005/UNDP and WBI John A. Dixon, Economics of Pollution Control The numbers can be large! For example, in 2010 the Monetized Benefits from the US Clean Air Act are estimated as follows:
6
GEF Caspian EVE 2005/UNDP and WBI John A. Dixon, Economics of Pollution Control Steps in Calculating Health Benefits for Air or Water Quality Improvements Predict change in emissions of criteria pollutants associated with air/ water quality regulations Translate changes in emissions into population-weighted changes in ambient exposures Calculate associated changes in health outcomes Reduced premature mortality Reduced hospital admissions Fewer cases of chronic bronchitis or diarrhea Assign a dollar value to cases of illness, mortality avoided
7
GEF Caspian EVE 2005/UNDP and WBI John A. Dixon, Economics of Pollution Control Air Pollution Example: Studies of the Health Impacts Examine effects of acute air pollution exposure on Premature death Hospital admissions for heart, lung disease Emergency room visits for heart, lung disease Work-loss days Examine effects of chronic exposure on Premature death Chronic bronchitis
8
GEF Caspian EVE 2005/UNDP and WBI John A. Dixon, Economics of Pollution Control Interpretation of Dose-Response Function (or DRR) Dose-response function relates health effects to air pollution concentrations and other factors affecting health Slope of dose-response function measures the percentage change in the health outcome for a one unit change in PM10 For example, a 10 microgram reduction in PM10 reduces deaths by about 4% in studies of the impact of long-term exposure to air pollution on deaths
9
GEF Caspian EVE 2005/UNDP and WBI John A. Dixon, Economics of Pollution Control Projected Reductions in Illness due to the US Clean Air Act, Titles I - V Health EndpointPollutant2010 Mean reduction Mortality Age 30+PM et al23,000 Chronic Illness Chronic bronchitis Chronic asthma PM Ozone 20,000 7,200 Hospitalization Respiratory admissions Cardiovascular admissions Asthma-related emergency room visits PM, CO, NO 2, SO 2, Ozone PM, Ozone 22,000 42,000 4,800 Minor Illness Avoided respiratory illnesses and symptom-days, asthma attacks, work loss days, etc. PM, NO 2, SO 2, OzoneMillions of cases/incidence
10
GEF Caspian EVE 2005/UNDP and WBI John A. Dixon, Economics of Pollution Control Valuing Environmental Health Effects The Damage Function Approach: Value of number of cases of illness/death avoided = Number of Cases Avoided * Value per Case Value per Case Avoided should reflect individual’s willingness to pay (WTP) to avoid illness or risk of death Human Capital/Cost of Illness Approach, which focuses on lost productivity, medical costs, generally serves as a lower bound to WTP
11
GEF Caspian EVE 2005/UNDP and WBI John A. Dixon, Economics of Pollution Control Valuing Risks to Life: What Is to Be Valued? Epidemiologic studies predict number of deaths avoided Treat these as equivalent to reducing risk of death for each person in the exposed population Risk reduction per person = (Number of deaths avoided)/(Size of exposed population)
12
GEF Caspian EVE 2005/UNDP and WBI John A. Dixon, Economics of Pollution Control Key Concepts Concept of a Statistical Life Reducing risk of death by 1 in 10,000 for each of 10,000 people saves one statistical life Value of a Statistical Life (VSL) If each of the 10,000 people is willing to pay $500 for the 1 in 10,000 risk reduction the Value of a Statistical Life is = 10,000 x $500 = $5,000,000
13
GEF Caspian EVE 2005/UNDP and WBI John A. Dixon, Economics of Pollution Control How to Measure WTP for a Reduction in Risk of Death? Labor Market Studies Use compensating wage differentials to value risks of death Contingent Valuation Studies Ask people directly what they would pay for a change in risk of death Averting Behavior Studies Use data on seatbelt use, purchase of smoke detectors, switch to low-tar cigarettes
14
GEF Caspian EVE 2005/UNDP and WBI John A. Dixon, Economics of Pollution Control Empirical Estimates of Value of a Statistical Life (VSL) in the US Value of Statistical Life estimates range between $ 1 - 10 million (1990 USD); USEPA’s preferred estimate is $4.8M (1990 USD) Problems: Average age of worker is 40—older than average age of person whose life is extended by an environmental program Estimates of VSL from Averting Behavior Studies almost one order of magnitude lower than in Labor Market Studies
15
GEF Caspian EVE 2005/UNDP and WBI John A. Dixon, Economics of Pollution Control Valuing Reductions in Morbidity (sickness) Private WTP for a reduction in risk of illness should reflect: Value of lost work time Value of lost leisure time Value of expenditures to treat illness Value of expenditures to avoid illness Discomfort (pain) of illness Value to Society of the Risk Reduction = Individual’s WTP plus reduction in costs borne by society Cost of Illness = Value of lost work time + Value of medical expenditures
16
GEF Caspian EVE 2005/UNDP and WBI John A. Dixon, Economics of Pollution Control Approaches to Valuing Morbidity Ask directly WTP to avoid illness or risk of illness Look at rate of substitution of one risk for another (Risk-Risk Tradeoffs) Use Cost of Illness estimates as a lower bound to WTP
17
GEF Caspian EVE 2005/UNDP and WBI John A. Dixon, Economics of Pollution Control Health Effects in the US: Valuation per health outcome (1990 $) EndpointPollutantValuation (mean est.) MortalityPM 10 4,800,000Per case Chronic BronchitisPM 10 260,000Per case Chronic AsthmaO3O3 25,000Per case Hospital Admissions All RespiratorySO 2, NO 2, PM 10,O 3 6,900Per case All CardiovascularSO 2, NO 2, CO, PM 10,O 3 9,500Per case Emergency Room Visits for AsthmaPM 10,O 3 194Per case Respiratory Illness and Symptoms Acute BronchitisPM 10 45Per case Asthma Attack or Moderate or Worse Asthma DayPM 10,O 3 32Per case Acute Respiratory SymptomsSO 2, NO 2, PM 10,O 3 18Per case Upper Respiratory SymptomsPM 10 19Per case Lower Respiratory SymptomsPM 10 12Per case Shortness of Breath, Chest Tightness, or WheezePM 10, SO 2 5.3Per day Work Loss DaysPM 10 83Per day Mild Restricted Activity DaysPM 10,O 3 38Per day
18
GEF Caspian EVE 2005/UNDP and WBI John A. Dixon, Economics of Pollution Control Valuing Morbidity and Mortality in the Caspian region Persian Gulf Environmental Damages (air pollution from burning oil wells) VSL calculations from Iran Other examples And don’t forget the other types of values: Amenities Ecosystem effects Agricultural/ fisheries production
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.